The company disclosed a scheduled Analyst/Investor Meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The disclosure explicitly states that no unpublished price-sensitive information (UPSI) is proposed to be shared during the meeting.
The company noted that the meeting schedule may undergo changes due to exigencies on the part of the Analyst/Investor or the Company.
The information about the meeting is available on the company's website at www.irisregtech.com.
The disclosure was signed by Santoshkumar Sharma, Company Secretary & Compliance Officer (ICSI Membership No. ACS 35139).
Additional Notes Section
The document is a regulatory filing submitted to both BSE Limited and National Stock Exchange of India Limited.
No specific date, time, management participants, presentation materials, or financial data were disclosed in this announcement.
The disclosure serves purely as an intimation of a scheduled meeting without providing operational or financial details.
